MindBio Therapeutics Corp.
MBIO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -790.30K | -922.50K | -590.80K | -247.20K | -30.70K |
| Total Depreciation and Amortization | -- | -56.80K | 0.00 | 57.80K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 764.20K | 467.40K | 623.40K | 60.00K | -67.70K |
| Change in Net Operating Assets | -1.50K | 375.70K | -70.70K | 38.00K | 44.50K |
| Cash from Operations | -27.60K | -136.20K | -38.20K | -91.40K | -53.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 6.40K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 6.40K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -1.30K | 0.00 | 0.00 | -8.00K |
| Issuance of Common Stock | -- | 275.40K | -- | 165.00K | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -400.00 | -- | -- | -- |
| Cash from Financing | -- | 175.40K | 0.00 | 107.50K | -5.40K |
| Foreign Exchange rate Adjustments | -- | -13.60K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.60K | 31.90K | -38.20K | 16.20K | -59.20K |